ethoxidine and Disease-Models--Animal

ethoxidine has been researched along with Disease-Models--Animal* in 1 studies

Other Studies

1 other study(ies) available for ethoxidine and Disease-Models--Animal

Article	Year
Pro-Angiogenic Effects of Low Dose Ethoxidine in a Murine Model of Ischemic Hindlimb: Correlation between Ethoxidine Levels and Increased Activation of the Nitric Oxide Pathway. Molecules (Basel, Switzerland), 2017, Apr-12, Volume: 22, Issue:4 Ethoxidine, a benzo[c]phenanthridine derivative, has been identified as a potent inhibitor of topoisomerase I in cancer cell lines. Our group has reported paradoxical properties of ethoxidine in cellular processes leading to angiogenesis on endothelial cells. Because low concentration ethoxidine is able to favor angiogenesis, the present study aimed to investigate the ability of 10 Topics: Angiogenesis Inducing Agents; Animals; Blood Pressure; Body Weight; Disease Models, Animal; Hindlimb; Ischemia; Male; Mice; Molecular Structure; Muscle, Skeletal; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase Type III; Phenanthridines; Signal Transduction; Vascular Endothelial Growth Factor A	2017

Article

Year

Pro-Angiogenic Effects of Low Dose Ethoxidine in a Murine Model of Ischemic Hindlimb: Correlation between Ethoxidine Levels and Increased Activation of the Nitric Oxide Pathway.

Molecules (Basel, Switzerland), 2017, Apr-12, Volume: 22, Issue:4

Ethoxidine, a benzo[c]phenanthridine derivative, has been identified as a potent inhibitor of topoisomerase I in cancer cell lines. Our group has reported paradoxical properties of ethoxidine in cellular processes leading to angiogenesis on endothelial cells. Because low concentration ethoxidine is able to favor angiogenesis, the present study aimed to investigate the ability of 10

Topics: Angiogenesis Inducing Agents; Animals; Blood Pressure; Body Weight; Disease Models, Animal; Hindlimb; Ischemia; Male; Mice; Molecular Structure; Muscle, Skeletal; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase Type III; Phenanthridines; Signal Transduction; Vascular Endothelial Growth Factor A

2017